Leap Therapeutics, Inc.

Historical 13F Holders

Symbol
CYPH
CUSIP
52187K200
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 52187K200 since 12/18/2024, largest first.

Filer % of Class Filed
Winklevoss Capital Fund, LLC 13D/A
19.9% 8/19/2026
Event 8/17/2026
Severns Sean Michael 13G 10.6% 11/18/2025
Event 11/12/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
BeiGene, Ltd. 13D/A 0% 10/31/2024
Event 10/31/2024
Balyasny Asset Management L.P. 13G/A
0% 2/14/2025
Event 12/31/2024
Gilead Sciences, Inc. 13G/A 0% 2/12/2026
Event 12/31/2025
Samsara BioCapital, L.P. 13G/A
0% 8/14/2025
Event 6/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 81 20.8 M $69.3M
2026 Q2 48 14.9 M $9.13M
2026 Q1 42 7.32 M $5.94M
2025 Q4 40 8.63 M $10.0M
2025 Q3 34 12.7 M $5.76M
2025 Q2 44 13.8 M $4.08M
2025 Q1 47 16.7 M $5.09M
2024 Q4 58 19.2 M $55.3M
2024 Q3 49 14.7 M $37.8M
2024 Q2 47 14.7 M $28.9M
2024 Q1 45 8.47 M $22.5M
2023 Q4 45 6.86 M $28.4M
2023 Q3 44 7.74 M $10.6M
2023 Q2 39 7.71 M $24.1M